Korea To Cut Drug Prices By Up To 20% For Inferior Efficacy Results; More Cuts Expected
This article was originally published in PharmAsia News
SEOUL - South Korea's Ministry of Health and Welfare will cut prices of 664 drugs by up to 20% after conducting a peer drug review of 2,398 products. The cuts will begin in July and will roll out over the next three years
You may also be interested in...
SEOUL - In its first action following a warning in 2009 about drug rebates, the Korea Ministry of Health and Welfare is moving to cut market prices for 131 products manufactured by seven local Korean pharma companies by as high as 20%
SEOUL - South Korea's Ministry of Health and Welfare is moving to charge patients more for drugs when they visit large general hospitals for minor ailments in an effort to deter public preference away from large hospitals, which has overburdened the country's national medical insurance system.
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).